Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB Cells for Enhanced Osseointegration in Dental Implant Surgery
NCT04451486Phase 1Unknown
- Sponsor
- Taipei Medical University
- Start
- Aug 2018
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of SB cell in Alveolar bone loss (3 arms), sponsored by Taipei Medical University. Primary endpoint: Number of participants with adverse events at 1 year. Status: unknown.
02
Drugs
SB cell
03
Conditions
Alveolar bone loss
Beyond the preview
Go deeper on NCT04451486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04451486.